LIGAND PHARMACEUTICALS INC - NOTE 0.750% 8/1

Historical Holders from Q3 2015 to Q1 2020

Type / Class
Debt / NOTE 0.750% 8/1
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Institutional Holders of LIGAND PHARMACEUTICALS INC - NOTE 0.750% 8/1 across Reporting Periods

Period Principal Value Change Price (% of par) Investors
2020 Q1 $0 $0 -$3,882 0
2019 Q3 $39 $3,882 -$39,777,118 9953.85% 1
2019 Q2 $26,328,000 $39,781,000 -$2,032,019 151.19% 5
2019 Q1 $27,464,000 $45,945,000 -$64,040 167.45% 5
2018 Q4 $27,461,000 $49,776,000 -$361,984,202 180.88% 6
2018 Q3 $127,907,000 $453,455,000 -$195,070,770 364.65% 12
2018 Q2 $181,116,000 $498,208,000 -$114,297,457 275.16% 12
2018 Q1 $229,681,000 $503,037,000 -$8,237,722 218.94% 17
2017 Q4 $243,307,000 $444,694,000 +$3,644,154 182.75% 23
2017 Q3 $241,457,000 $440,973,000 -$93,512 182.44% 25
2017 Q2 $242,680,000 $402,344,000 +$4,745,433 165.84% 25
2017 Q1 $244,180,000 $364,402,000 +$6,247,247 149.21% 26
2016 Q4 $241,400,000 $349,770,000 -$4,791,291 144.66% 24
2016 Q3 $244,297,000 $357,451,000 -$2,220,426 146.35% 25
2016 Q2 $242,690,000 $406,052,000 -$4,247,849 167.05% 24
2016 Q1 $245,697,000 $373,336,000 -$1,423,530 152.44% 22
2015 Q4 $245,621,600 $382,007,000 +$2,451,786 155.03% 22
2015 Q3 $241,761,170 $314,220,141 +$282,556,141 129.96% 25